April 3 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL'S LEAD CANDIDATE COMBINED WITH KEYTRUDA®: STRONG EVIDENCE OF RAPID ADDITIVE OR SYNERGISTIC ANTI-TUMOR ACTIVITY
* BRIACELL THERAPEUTICS CORP - COMBINATION WAS VERY SAFE AND WELL-TOLERATED IN ALL 6 PATIENTS OF STUDY